Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
Clinical trial NCT05318612 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05318612
- Sponsor
- Radboud University Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-08
- Primary completion
- 2025-10-31
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.